NLR and PLR as novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF

dc.authoridDüzenli, Tolga / 0000-0002-6279-1018
dc.authorscopusid57200372265
dc.authorscopusid56004154000
dc.authorscopusid21833712000
dc.contributor.authorDüzenli, Tolga
dc.contributor.authorKöseoğlu, Hüseyin
dc.contributor.authorAkyol, Taner
dc.date.accessioned2021-11-01T14:51:37Z
dc.date.available2021-11-01T14:51:37Z
dc.date.issued2020
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractTo the Editors, We read with curiosity the recently published article titled “Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF: Neutrophil to Lymphocyte Ratio and Platelet-toLymphocyte Ratio” by Bertani et al.1 In the article, authors aimed to assess whether neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) could be used as prognostic markers of antitumor necrosis factor (anti-TNF) treatment response in patients with ulcerative colitis.
dc.identifier.citationDüzenli, T., Köseoğlu, H., & Akyol, T. (2020). NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF. Inflammatory Bowel Diseases, 26(9), e103-e103.
dc.identifier.doi10.1093/ibd/izaa153
dc.identifier.issn1078-0998
dc.identifier.issue9en_US
dc.identifier.pmid32514550
dc.identifier.scopus2-s2.0-85089787793
dc.identifier.scopusqualityQ1
dc.identifier.startpageE103en_US
dc.identifier.urihttps://doi.org/10.1093/ibd/izaa153
dc.identifier.urihttps://hdl.handle.net/11491/6221
dc.identifier.volume26en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorDüzenli, Tolga
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofInflammatory Bowel Diseases
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleNLR and PLR as novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF
dc.typeLetter

Dosyalar